Evaluation of the JUICE HA® as an Anti-sarcopenia

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-06-13

Study Completion Date

2026-03-13

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study plans to recruit 60 participants aged 65 years and older who have been diagnosed with sarcopenia by a physician. Participants will be randomly assigned into JUICE HA® supplement and placebo group. All of the participants will be asked to take 15 mL/day of JUICE HA® supplement or placebo group for 12 weeks. The aim of this trial is to evaluate the potential of JUICE HA® to enhance physiological status (muscle mass and functional fitness) and to improve the quality of life in patients with sarcopenia.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Nutrition Ameliorates the Muscle Loss of Pre-sarcopenia in Elderly

NCT07309120

Low Muscle Mass Low Muscle Strength Low Physical Function

COMPLETED NA

Protein Supplementation Intervention for Improving Muscle Mass and Physical Performance in Older People With Sarcopenia

NCT04516421

Sarcopenia

UNKNOWN NA

Dietary Supplements and Aging Muscle

NCT01057082

Sarcopenia

COMPLETED NA

Effects of Dietary Supplements on Sarcopenic Elders

NCT03860194

Sarcopenia

COMPLETED NA

Intervention Assessing the Role of Exercise Program and Nutrition Supplement for Sarcopenia

NCT02374268

Sarcopenia

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

JUICE HA® is a nutritional supplement formulated with hyaluronic acid (HA), branched-chain amino acids (BCAA), and chondroitin. Hyaluronic acid contributes to enhancing hydration levels in the skin and connective tissues; BCAA promotes muscle protein synthesis and repair; and chondroitin is believed to support the structural integrity and functionality of joints. The synergistic combination of these components is anticipated to provide comprehensive, multidimensional support for individuals with sarcopenia, potentially alleviating symptoms and improving overall quality of life. Therefore, this study will explore 15 mL/day of JUICE HA® supplement to improve the muscle mass and functional fitness in the elderly with sarcopenia.

This study aims to recruit 60 participants aged 65 years and older who have been diagnosed with sarcopenia by a physician and meet the Asian Working Group for Sarcopenia (AWGS) 2019 diagnostic criteria. Participants will be enrolled in a randomized control-group pretest-posttest design and randomly assigned to receive either the JUICE HA® supplement or a placebo (Lin et al., 2021). Functional fitness assessments, the Sarcopenia Quality of Life questionnaire (SarQoL), and blood sample collections will be conducted at baseline, at the 6th and 12th weeks of the supplementation period, and at the 6th and 12th weeks of the follow-up period. Blood samples will be analyzed for oxidative stress markers (SOD, MDA), inflammatory markers (TNF-α, IL-10), and muscle synthesis and degradation indicators (mTOR, MuRF1, atrogin-1). Body composition assessments will be performed at baseline, at the 12th week of the supplementation period, and at the 12th week of the follow-up period.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sarcopenia in Elderly

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

60 participants aged 65 and above who have been diagnosed with sarcopenia will be randomly assigned into two groups using an envelope-drawing method: one group will receive the JUICE HA® supplement, while the other group will receive a placebo. The supplementation period will last for 12 weeks. Comparisons between the two groups will be conducted at baseline (pre-test) and after the intervention (post-test).

Primary Study Purpose

OTHER

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

JUICE HA® supplement

Bottle with 15 ml of JUICE HA® supplement

Group Type EXPERIMENTAL

JUICE HA® supplement

Intervention Type OTHER

Bottle of 15 mL JUICE HA® supplement will be taken once a day for 12 weeks.

Placebo

Bottle of 15 mL liquid (non-effective product).

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type OTHER

Bottle of 15 mL liquid (non-effective product) will be taken once a day for 12 weeks.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Placebo

Bottle of 15 mL liquid (non-effective product) will be taken once a day for 12 weeks.

Intervention Type OTHER

JUICE HA® supplement

Bottle of 15 mL JUICE HA® supplement will be taken once a day for 12 weeks.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participants that have been diagnosed with sarcopenia by a physician and meet the AWGS 2019 criteria for sarcopenia.

Exclusion Criteria

* Participants with a history of severe lower extremity musculoskeletal injuries within the past six months or those who have a fear of blood sampling will be excluded.

Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No